The effect of education on all-cause mortality risk in adults on a global scale.
Pfizer presses forward with once-daily GLP-1 pill in long-awaited move
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS